Researcher

    Patricia Conrod , Ph.D.

    patricia.conrod@umontreal.ca
    Patricia Conrod
    Research Axis
    Brain and Child Development
    Research Theme
    Development of psychopathologies
    Address
    CHUSJ - Centre de Recherche

    Phone
    514 345-4931 4051

    Online

    Title

    • Full Professor, Department of Psychiatry, Université de Montréal
    • Université de Montréal’s Dr. Julien/Marcelle and Jean Coutu Foundation Chair in Community Social Pediatrics          

    Internship opportunity(ies)

    Education

    • PhD, Clinical Psychology, McGill University, 1998
    • BA, Psychology (First Class Honours), McGill University, 1992

    Laboratory

    Conrodventure Lab

    (Conrodventurelab.com)

    Research Interests

    Patricia Conrod is a Clinical Psychologist and Professor of Psychiatry at Universite de Montreal. Her research team is based at the CHU Sainte-Justine Mother and Child Hospital Centre in Montreal. She was previously a Senior Clinical Lecturer in the Addictions Department, King’s College London (2003-2010). Her research focuses on cognitive, personality and biological risk factors for the development and maintenance of drug abuse and the factors that mediate the co-occurrence of addictive behaviours with other mental disorders. Her research findings have led to the development of new approaches to substance abuse treatment and prevention that target personality risk factors and the underlying motivational determinants of drug use in subtypes of substance misusers. She developed the Preventure Program, which is identified as an evidence-based drug and alcohol prevention program by a number of national registries of evidence-based programs and the U.S. Surgeon General’s Report on Addiction.  Dr. Conrod was a member of the King’s College London Research Ethics Committee (2005-2010) and served as Chair of the Institute of Psychiatry Research Ethics Committee (2008-2010).  She is an Associate Editor of Current Reviews in Drug Abuse and consults to the UN and the European Commission on guidelines for drug and alcohol prevention and has published extensively on this issue. Her research is funded by the Canadian Institutes of Health Research, Fondation de Recherche du Quebec - Santé, European Commission (Health and Humanities/Social Sciences), Medical Research Council-UK (MRC), National Health and Medical Research Council - Australia (NHMRC), and the U.S. National Institutes of Health.

    Research Topics

    • Adolescent Brain Development
    • Prevention
    • Addiction
    • Personality
    • Clinical trials
    • Cognitive Behavioural Therapy

    Awards and Distinctions

    • Université de Montréal’s Dr. Julien/Marcelle and Jean Coutu Foundation Chair in Community Social Pediatrics, Montreal, QC, 2015-2019
    • Fonds de Recherche en Santé du Québec, Salary Career Award, 2013-2017.
    • Chercheur Boursier – Junior2, Fondation de Recherche en Santé du Quebec, Canada. 2010-2013  
    • National Health & Medical Research Council (NHMRC), Research Grant, 2011-2016.
    • Medical Research, Research Grant, UK, 2010-2015
    • Fonds de Recherche en Santé du Québec (FRSQ), Research Scholar, 2010-2013
    • Vice Chancellor Post Doctorate Research Fellowship, 
    • Action on Addiction Research Fellow, Institute of Psychiatry, King’s College London, London, UK, 2003-2008
    • Postdoctoral Fellowship, Social Sciences and Humanities Research Council of Canada (SSHRC), 1998-2000
    • Doctoral Fellowship, Medical Research Council of Canada (MRC), 1995-1997
    • Doctoral Fellowship, Medical Research Council of Canada (MRC), 1993-1995
    • Doctoral Fellowship, Fond pour la Formation de Chercheurs et l'aide à la recherche (FCAR), 1993-1995 
    • Doctoral Fellowship, Medical Research Council of Canada (MRC), 1992-1993
    • Doctoral Fellowship, Fond pour la Formation de Chercheurs et l'Aide à la Recherche (FCAR), 1992-1993
    • University Scholar, BA, McGill University, Montreal, QC, 1992
    • Faculty Scholar, BA, McGill University, Montreal, QC, 1992
    • James McGill Award, BA, McGill University, Montreal, QC, 1991

    Major financing

    Canadian Institutes of Health Research (CIHR), ERA-NET, Fonds de recherche du Québec – Santé (FRSQ), U.S. National Institutes of Health, Medical and Health Research Council – Australia.

    Presentations

    • Conrod, P.J., (2017).  Innovation in Drug and Alcohol Prevention.  Plenary Address at the 35th Annual Research Seminar of the National Drug and Alcohol Research Centre, Sydney Australia.
    • Conrod, P.J. (2015).  Neurocognitive Correlates of the Variance Common and Unique to Externalising Disorders and Substance Misuse in Adolescence (and the Efficacy of Interventions Targeting these Neurocognitive Profiles). NIAAA NIDA Mini Convention, Frontiers in Addiction Research: Neurobiological and Behavioral Consequences of Drug and Alcohol Use during Development.
    • Conrod, P.J. (2015) Interventions targeting impulsivity and sensation seeking for youth substance use and externalizing problems.  Invited plenary address. 11th Annual ADHD Conference, Canadian ADHD Resource Alliance,  October 17  - 18, 2015  Vancouver Marriott Pinnacle Downtown Hotel, Vancouver, BC
    • Conrod, P.J – (2015) Invited Speaker.  Personality-Targeted interventions for youth substance use and mental health problems: preventative effects and youth subjective experiences. Third International Youth Mental Health Conference 2015, Place des Arts, Montreal, Canada 8th–10th October 2015
    • Conrod, P.J. (2013). Individual and population-level benefits of targeting impulsivity in school-based interventions.  Grand Rounds Address, Department of Psychiatry, University of Vermont, Nov, 2013.

    Most Important Publications

    1. Conrod, PJ, and Nikolaou, K (2016).  On the developmental neuropsychology of substance use disorders. Journal of Child Psychology and Psychiatry, Annual Research Reviews. J Child Psychol Psychiatry, 2016 Mar; 57(3):371-94.
    2. *Conrod PJ, O'Leary-Barrett M, Newton N, Topper L, Castellanos-Ryan N, Mackie  C, Girard A. Effectiveness of a selective, personality-targeted prevention program for adolescent alcohol use and misuse: a cluster randomized controlled trial. JAMA Psychiatry. 2013 Mar;70(3):334-42. PubMed PMID: 23344135.
    3. Newton NC, Conrod PJ, Slade T, Carragher N, Champion KE, Barrett EL, Kelly EV, Nair NK, Stapinski L, Teesson M. The long-term effectiveness of a selective, personality-targeted prevention program in reducing alcohol use and related harms: a cluster randomized controlled trial. J Child Psychol Psych. 2016, Apr 19.
    4. O'Leary-Barrett M, Castellanos-Ryan N, Pihl RO, *Conrod PJ. Mechanisms of personality-targeted intervention effects on adolescent alcohol misuse, internalizing and externalizing symptoms. J Consult Clin Psychol. 2016 May;84(5):438-52. PubMed PMID: 26881449.
    5. Bourque, J., Schachler, P., Whelan, R., Banaschewski, T, Bokde, A,  Bromberg, U, Büchel, C, Flor, H, Frouin, V, Gallinat, J, Garavan, H, Martinot, JL Nees, F, Paus, T, Pausova, Z, Rietschel, M, Smolka, MN, Whelan, R, Schumann, G, Conrod PJ.  Functional Neuroimaging predictors of self-report psychotic symptoms in adolescents. Am J Psychiatry, 2017 Jun 1:174(6): 566-575.
    6. Castellanos-Ryan N, Brière FN, O'Leary-Barrett M, Banaschewski T, Bokde A, Bromberg U, Büchel C, Flor H, Frouin V, Gallinat J, Garavan H, Martinot JL, Nees F, Paus T, Pausova Z, Rietschel M, Smolka MN, Robbins TW, Whelan R, Schumann G, Conrod P; IMAGEN Consortium.  The structure of psychopathology in adolescence and its common personality and cognitive correlates. J Abnorm Psychol. 2016 Nov;125(8):1039-1052. PMID: 27819466.
    7. Castellanos-Ryan N, Struve M, Whelan R, Banaschewski T, Barker GJ, Bokde AL,  Bromberg U, Büchel C, Flor H, Fauth-Bühler M, Frouin V, Gallinat J, Gowland P, Heinz A, Lawrence C, Martinot JL, Nees F, Paus T, Pausova Z, Rietschel M, Robbins TW, Smolka MN, Schumann G, Garavan H, Conrod PJ; IMAGEN Consortium. Neural and cognitive correlates of the common and specific variance across externalizing problems in young adolescence. Am J Psychiatry. 2014 Dec 1;171(12):1310-9. doi: 10.1176/appi.ajp.2014.13111499. Epub 2014 Oct 31. PubMed PMID: 25073448.
    8. Mahu IT, Doucet C, O'Leary-Barrett M, *Conrod PJ. Can cannabis use be prevented by targeting personality risk in schools? Twenty-four-month outcome of  the adventure trial on cannabis use: a cluster-randomized controlled trial. Addiction. 2015 Oct;110(10):1625-33. PubMed PMID: 26011508
    9. O'Leary-Barrett M, Topper L, Al-Khudhairy N, Pihl RO, Castellanos-Ryan N, Mackie CJ, *Conrod PJ. Two-year impact of personality-targeted, teacher-delivered interventions on youth internalizing and externalizing problems: a cluster-randomized trial. J Am Acad Child Adolesc Psychiatry. 2013 Sep;52(9):911-20. PubMed PMID: 23972693
    10. Baker, T., Tuchulka, T, Zang, L,  Larcher, K, Jutras-Aswad, D, Lesperance, P, Conrod, PJ. Reversing the atypical valuation of drug and nondrug rewards in smokers using multi-modal neuroimaging involving Transcranial Magnetic Stimulation (TMS). Biol Psychiatry. 2017 Jan 27. pii: S0006-3223(17)30084-7. doi: 10.1016/j.biopsych.2017.01.015

Related news

About this page
Edited by Hoffmann Maude

Created on 9/18/2014
Alert or send a suggestion

Every dollar counts!

Thank you for your generosity.

It's people like you that allow us to accelerate research and heal more children better every year and, as such, offer among the best healthcare in the world.

It's also possible to give by mail or by calling toll-free

1-888-235-DONS (3667)

Contact Us

514 345-4931

Légal

© 2006-2014 CHU Sainte-Justine.
All rights reserved.
Terms of Use, Confidentiality, Security

Avertissement

Les informations contenues dans le site « CHU Sainte-Justine » ne doivent pas être utilisées comme un substitut aux conseils d’un médecin dûment qualifié et autorisé ou d’un autre professionnel de la santé. Les informations fournies ici le sont à des fins exclusivement éducatives et informatives.

Consultez votre médecin si vous croyez être malade ou composez le 911 pour toute urgence médicale.

CHU Sainte-Justine